Sleep quality and quality of life in patients with hypertrophic cardiomyopathy.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 21150200)

Published in Cardiology on December 08, 2010

Authors

Rodrigo P Pedrosa1, Sandro G Lima, Luciano F Drager, Pedro R Genta, Aline C S Amaro, Murillo O Antunes, Edmundo Arteaga, Charles Mady, Geraldo Lorenzi-Filho

Author Affiliations

1: Sleep Laboratory, Pulmonary Division, Heart Institute (InCor), Hospital das Clínicas da Faculdade de Medicina, Universidade de São Paulo, Av. Enéas Carvalho de Aguiar 44, São Paulo, Brazil.

Articles by these authors

Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med (2005) 2.67

The incremental role of obstructive sleep apnoea on markers of atherosclerosis in patients with metabolic syndrome. Atherosclerosis (2009) 2.42

Effects of oropharyngeal exercises on patients with moderate obstructive sleep apnea syndrome. Am J Respir Crit Care Med (2009) 2.20

CPAP has no effect on clearance, sputum properties, or expectorated volume in cystic fibrosis. Respir Care (2012) 1.99

Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension (2011) 1.92

Clinical predictors of the respiratory arousal threshold in patients with obstructive sleep apnea. Am J Respir Crit Care Med (2014) 1.91

Additive effects of obstructive sleep apnea and hypertension on early markers of carotid atherosclerosis. Hypertension (2008) 1.90

Randomized, prospective trial of oxygen, continuous positive airway pressure, and bilevel positive airway pressure by face mask in acute cardiogenic pulmonary edema. Crit Care Med (2004) 1.79

Periodic breathing during incremental exercise predicts mortality in patients with chronic heart failure evaluated for cardiac transplantation. J Am Coll Cardiol (2003) 1.72

Noncompaction cardiomyopathy: a current view. Arq Bras Cardiol (2011) 1.65

Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. J Am Coll Cardiol (2013) 1.65

Effects of OSA treatment on BP in patients with resistant hypertension: a randomized trial. Chest (2013) 1.64

Obstructive sleep apnea, masked hypertension, and arterial stiffness in men. Am J Hypertens (2009) 1.61

The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome. PLoS One (2010) 1.51

The role of echocardiography in diagnosis and management of isolated meningococcal pericarditis. Echocardiography (2007) 1.51

Sleep-related changes in hemodynamic and autonomic regulation in human hypertension. J Hypertens (2009) 1.47

Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity. J Am Coll Cardiol (2005) 1.43

II Guidelines for perioperative evaluation of the Brazilian Society of Cardiology. Arq Bras Cardiol (2011) 1.41

Effects of different acute hypoxic regimens on tissue oxygen profiles and metabolic outcomes. J Appl Physiol (1985) (2011) 1.41

Obstructive sleep apnea, hypertension, and their interaction on arterial stiffness and heart remodeling. Chest (2007) 1.38

Late gadolinium enhancement magnetic resonance imaging in the diagnosis and prognosis of endomyocardial fibrosis patients. Circ Cardiovasc Imaging (2011) 1.34

Characteristics and predictors of obstructive sleep apnea in patients with systemic hypertension. Am J Cardiol (2010) 1.27

Effects of massage therapy on sleep quality after coronary artery bypass graft surgery. Clinics (Sao Paulo) (2010) 1.21

Effects of exercise training in patients with chronic heart failure and sleep apnea. Sleep (2009) 1.14

Dysautonomia due to reduced cholinergic neurotransmission causes cardiac remodeling and heart failure. Mol Cell Biol (2010) 1.12

Cheyne-Stokes respiration in patients with congestive heart failure: causes and consequences. Clinics (Sao Paulo) (2005) 1.12

Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/"indeterminate" and Chagas disease cardiomyopathy patients. Mem Inst Oswaldo Cruz (2003) 1.11

Yoga respiratory training improves respiratory function and cardiac sympathovagal balance in elderly subjects: a randomised controlled trial. BMJ Open (2011) 1.11

Is the cardiovascular system the primary target of obstructive sleep apnea? Am J Respir Crit Care Med (2008) 1.09

The effects of continuous positive airway pressure on prehypertension and masked hypertension in men with severe obstructive sleep apnea. Hypertension (2011) 1.09

Impact of OSA on cardiovascular events after coronary artery bypass surgery. Chest (2015) 1.08

Consequences of comorbid sleep apnea in the metabolic syndrome--implications for cardiovascular risk. Sleep (2010) 1.08

Cardiovascular effects of partial sleep deprivation in healthy volunteers. J Appl Physiol (1985) (2012) 1.07

Heterozygosity for the S180L variant of MAL/TIRAP, a gene expressing an adaptor protein in the Toll-like receptor pathway, is associated with lower risk of developing chronic Chagas cardiomyopathy. J Infect Dis (2009) 1.02

Sleep quality in patients with fibromyalgia using the Pittsburgh Sleep Quality Index. J Rheumatol (2006) 1.02

Cardiac remodeling in patients with systemic sclerosis with no signs or symptoms of heart failure: an endomyocardial biopsy study. J Card Fail (2003) 1.02

Myocardial chemokine expression and intensity of myocarditis in Chagas cardiomyopathy are controlled by polymorphisms in CXCL9 and CXCL10. PLoS Negl Trop Dis (2012) 1.00

Intermittent hypoxia impairs glucose homeostasis in C57BL6/J mice: partial improvement with cessation of the exposure. Sleep (2013) 1.00

Influence of Cheyne-Stokes respiration on cardiovascular oscillations in heart failure. Am J Respir Crit Care Med (2003) 1.00

Effects of yoga and the addition of Tui Na in patients with fibromyalgia. J Altern Complement Med (2007) 0.99

Effects of sleep apnea on nocturnal free fatty acids in subjects with heart failure. Sleep (2011) 0.98

TNF blockade aggravates experimental chronic Chagas disease cardiomyopathy. Microbes Infect (2007) 0.97

Effect of Losartan on left ventricular diastolic function in patients with nonobstructive hypertrophic cardiomyopathy. Am J Cardiol (2005) 0.96

Identification of multiple HLA-A*0201-restricted cruzipain and FL-160 CD8+ epitopes recognized by T cells from chronically Trypanosoma cruzi-infected patients. Microbes Infect (2005) 0.96

Provocation of ventricular ectopy by cheyne-stokes respiration in patients with heart failure. Sleep (2004) 0.95

Acute cardiopulmonary alterations induced by fine particulate matter of São Paulo, Brazil. Toxicol Sci (2005) 0.95

The Syrian hamster as a model for the dilated cardiomyopathy of Chagas' disease: a quantitative echocardiographical and histopathological analysis. Microbes Infect (2003) 0.95

Effects of cyclosporine A and bronchial transection on mucociliary transport in rats. Ann Thorac Surg (2008) 0.95

Acute hypoxia induces hypertriglyceridemia by decreasing plasma triglyceride clearance in mice. Am J Physiol Endocrinol Metab (2012) 0.94

Resistant hypertension optimal treatment trial: a randomized controlled trial. Clin Cardiol (2013) 0.94

Obstructive sleep apnea and surgery: wake up for the problem! Rev Port Pneumol (2013) 0.94

Cyclosporin A reduces airway mucus secretion and mucociliary clearance in rats. Clinics (Sao Paulo) (2007) 0.92

Obstructive sleep apnea is common among patients referred for coronary artery bypass grafting and can be diagnosed by portable monitoring. Coron Artery Dis (2012) 0.92

Mucociliary clearance is impaired in acutely ill patients. Chest (2005) 0.92

TNF gene polymorphisms are associated with reduced survival in severe Chagas' disease cardiomyopathy patients. Microbes Infect (2005) 0.92

Obstructive sleep apnea is common and independently associated with atrial fibrillation in patients with hypertrophic cardiomyopathy. Chest (2010) 0.91

The extracellular matrix of the lateral pharyngeal wall in obstructive sleep apnea. Sleep (2012) 0.91

Sleep Apnea Cardiovascular Clinical Trials-Current Status and Steps Forward: The International Collaboration of Sleep Apnea Cardiovascular Trialists. Sleep (2013) 0.91

Reference values from M-mode and Doppler echocardiography for normal Syrian hamsters. Eur J Echocardiogr (2005) 0.91

Obstructive sleep apnea syndrome in truck drivers. J Bras Pneumol (2009) 0.91

Chronic intermittent hypoxia induces lung growth in adult mice. Am J Physiol Lung Cell Mol Physiol (2010) 0.90

Influence of pregnancy on clinical course and fetal outcome of women with hypertrophic cardiomyopathy. Arq Bras Cardiol (2007) 0.90

Clinical, electrocardiographic and echocardiographic findings in significant cardiac amyloidosis detected only at necropsy: comparison with cases diagnosed in life. Arq Bras Cardiol (2008) 0.90

I Brazilian guidelines on myocarditis and pericarditis. Arq Bras Cardiol (2013) 0.90

Myocardial fibrosis detected by cardiac CT predicts ventricular fibrillation/ventricular tachycardia events in patients with hypertrophic cardiomyopathy. J Cardiovasc Comput Tomogr (2013) 0.89

Continuous positive airway pressure delivered by oronasal mask may not be effective for obstructive sleep apnoea. Eur Respir J (2012) 0.89

The effect of beta-blockade on myocardial remodelling in Chagas' cardiomyopathy. Clinics (Sao Paulo) (2012) 0.89

Left atrial diameter is independently associated with arterial stiffness in patients with obstructive sleep apnea: potential implications for atrial fibrillation. Int J Cardiol (2009) 0.89

Effect of chronic intermittent hypoxia on triglyceride uptake in different tissues. J Lipid Res (2013) 0.88

BAT1, a putative anti-inflammatory gene, is associated with chronic Chagas cardiomyopathy. J Infect Dis (2006) 0.88

[Heart failure with preserved systolic function]. Arq Bras Cardiol (2004) 0.88

Obstructive sleep apnea is associated with increased chemoreflex sensitivity in patients with metabolic syndrome. Sleep (2013) 0.88

Metabolic consequences of high-fat diet are attenuated by suppression of HIF-1α. PLoS One (2012) 0.87

The monocyte chemoattractant protein-1 gene polymorphism is associated with cardiomyopathy in human chagas disease. Clin Infect Dis (2006) 0.87